Usana Health Sciences (USNA) Long-Term Deferred Tax (2016 - 2026)
Usana Health Sciences (USNA) has disclosed Long-Term Deferred Tax for 16 consecutive years, with $27.2 million as the latest value for Q1 2026.
- Quarterly Long-Term Deferred Tax rose 38.51% to $27.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $27.2 million through Jan 2026, up 38.51% year-over-year, with the annual reading at $27.2 million for FY2026, 38.51% up from the prior year.
- Long-Term Deferred Tax for Q1 2026 was $27.2 million at Usana Health Sciences, up from $24.2 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $27.2 million in Q1 2026, with the low at $4.5 million in Q2 2022.
- Average Long-Term Deferred Tax over 5 years is $15.2 million, with a median of $15.1 million recorded in 2023.
- Peak annual rise in Long-Term Deferred Tax hit 138.23% in 2022, while the deepest fall reached 12.04% in 2022.
- Over 5 years, Long-Term Deferred Tax stood at $9.8 million in 2022, then surged by 35.56% to $13.3 million in 2023, then skyrocketed by 47.88% to $19.6 million in 2024, then grew by 22.97% to $24.2 million in 2025, then grew by 12.63% to $27.2 million in 2026.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods came in at $27.2 million, $24.2 million, and $26.4 million for Q1 2026, Q3 2025, and Q2 2025 respectively.